Literature DB >> 1298980

The problem of thalassemia in Thailand.

V Panich1, M Pornpatkul, W Sriroongrueng.   

Abstract

About one per cent of the Thai population are affected with thalassemic diseases. In each year there are almost 50,000 pregnancies at risk of having an affected fetus, one fourth of which result in thalassemic newborns. Both alpha- and beta -thalassemia, including hemoglobins E and Constant Spring, are common in Thailand. Their distribution varies from region to region and among different ethnic groups. About 30-40% of the population are carriers of at least one of the abnormal genes. Thalassemias and hemoglobinopathies are common and heterogeneous in Thailand. They combine to give more than 60 thalassemic syndromes with varying clinical severity. Abnormalities can be detected in every organ system. Studies in detail into each clinical problem will lead to better management. Hematological and molecular studies on different types of thalassemia in Thailand have made it possible to give prenatal diagnosis service to those pregnancies at risk of having a thalassemic child. Sporadic services have been given in three centers. Systematic prevention and control program is being planned by the cooperation of both the public and private sectors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1298980

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

1.  Pregnancy outcomes among women affected with thalassemia traits.

Authors:  Pornpimol Ruangvutilert; Chayawat Phatihattakorn; Chutima Yaiyiam; Tachjaree Panchalee
Journal:  Arch Gynecol Obstet       Date:  2022-03-26       Impact factor: 2.344

2.  Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand.

Authors:  Utsana Tonmukayakul; Román Pérez Velasco; Sripen Tantivess; Yot Teerawattananon
Journal:  BMC Public Health       Date:  2012-05-30       Impact factor: 3.295

3.  No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease.

Authors:  Surapong Lertthammakiat; Peerasit Sitthirat; Usanarat Anurathapan; Duantida Songdej; Samart Pakakasama; Ampaiwan Chuansumrit; Nattaphat Putawornsub; Sawitt Sirasittikarn; Sataporn Wantanawijarn; Praguywan Kadegasem; Suradej Hongeng; Nongnuch Sirachainan
Journal:  Thromb J       Date:  2020-09-04

4.  A novel TCN2 mutation with unusual clinical manifestations of hemolytic crisis and unexplained metabolic acidosis: expanding the genotype and phenotype of transcobalamin II deficiency.

Authors:  Pongpak Pongphitcha; Nongnuch Sirachainan; Arthaporn Khongkraparn; Thipwimol Tim-Aroon; Duantida Songdej; Duangrurdee Wattanasirichaigoon
Journal:  BMC Pediatr       Date:  2022-04-29       Impact factor: 2.567

5.  Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program.

Authors:  Rosarin Sruamsiri; Nathorn Chaiyakunapruk; Samart Pakakasama; Somtawin Sirireung; Nintita Sripaiboonkij; Udomsak Bunworasate; Suradej Hongeng
Journal:  BMC Health Serv Res       Date:  2013-02-05       Impact factor: 2.655

6.  Efficacy of Oral Acetaminophen and Intravenous Chlorpheniramine Maleate versus Placebo to Prevent Red Cell Transfusion Reactions in Children and Adolescent with Thalassemia: A Prospective, Randomized, Double-Blind Controlled Trial.

Authors:  Piya Rujkijyanont; Chalinee Monsereenusorn; Pimpat Manoonphol; Chanchai Traivaree
Journal:  Anemia       Date:  2018-10-01

7.  Clinical utility of combined preimplantation genetic testing methods in couples at risk of passing on beta thalassemia/hemoglobin E disease: A retrospective review from a single center.

Authors:  Chonthicha Satirapod; Matchuporn Sukprasert; Bhakbhoom Panthan; Angkana Charoenyingwattana; Pawares Chitayanan; Wasun Chantratita; Wicharn Choktanasiri; Objoon Trachoo; Suradej Hongeng
Journal:  PLoS One       Date:  2019-11-21       Impact factor: 3.240

8.  Leukocyte telomere length in patients with transfusion-dependent thalassemia.

Authors:  Nithita Nanthatanti; Adisak Tantiworawit; Pokpong Piriyakhuntorn; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Wirote Tuntiwechapikul; Kanda Fanhchaksai; Pimlak Charoenkwan; Sirinart Kumfu; Nipon Chattipakorn
Journal:  BMC Med Genomics       Date:  2020-06-01       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.